Merck KGaA has entered into a definitive agreement to buy the German microbiology business Biotest AG.
The acquisition allows the Merck Millipore division to complete its product portfolio in the attractive growth segment industrial microbiology for contamination detection.
Klaus Bischoff, Head of the Lab Solutions business unit within Merck Millipore, says the company has bought a business with a “motivated, customer-oriented workforce”.
Biotest AG has almost 300 employees in two locations in Germany, plus subsidiaries in France, Japan and in the US, and had sales last year of approximately €50 million.
The business will add to Merck’s existing dehydrated cell culture media and testing systems used in the pharmaceutical, food and beverage and personal-care industries.
Professor Gregor Schulz, President of the Board of Biotest AG, says the deal is beneficial to both parties.
“I am strongly convinced that due to the strong strategic fit and the geographic proximity, Merck will be able to develop the business further and offer employees good perspectives for the future,” he said.
The closing of the transaction is expected later in the year.